Prescription drug · ANDA
Carbinoxamine Maleate NDC 80705-120
Carbinoxamine maleate 6 mg/1 · Tablet · Oral · TRIPOINT THERAPEUTICS, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80705-120-30 | 80705012030 | 30 TABLET in 1 BOTTLE (80705-120-30)Marketed from Jul 22, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carbinoxamine Maleate
- Generic name (nonproprietary)
- carbinoxamine maleate
- Active ingredients
- Carbinoxamine maleate — 6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- TRIPOINT THERAPEUTICS, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215476
- Marketing start
- Listing expires
- Other FDA classes
- Histamine H1 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 80705-120_28237aea-8a3c-40ca-b2a1-0b7248ce5b99SPL ID 28237aea-8a3c-40ca-b2a1-0b7248ce5b99SPL set ID 91ee2e99-082a-4157-b71b-1a7c0e5464faRxCUI 1795581UNII 02O55696WHUPC 0380705120303
- Pharmacologic class
- Histamine-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480705012030followed by a unit qualifier and the quantityPackage 80705-0120-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Carbinoxamine maleate is effective for the symptomatic treatment of: Seasonal and perennial allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Dermatographism. As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. Amelioration of the severity of allergic reactions to blood or plasma.
Excerpt only. Read the full label for complete information.